Communications
Kinexus is striving to be a world leader in development and application of proteomics and bioinformatics for the discovery of novel diagnostics and therapeutics based on leading-edge knowledge of cellular communication systems. To this end, we have created a unique business model where our clients are
also our valued partners in the common pursuit of knowledge for the betterment of human health. Our shareholders are not only seeking a financial return on their investment, but they also want their investment to foster the development of personalized medicine to reduce disease and improve human wellfare.
Press Releases
Press Releases
A list of our press releases appear below. We have included a PDF the original full length news release for your convenience as well as any related links whenever possible. They are listed in descending order based on the date and year of publication. Please contact us at info@kinexus.ca for additional information on any of the news events described in these documents or to have future new releases e-mailed to you as they occur.
2010 Press Releases
February 8, 2010 - Kinexus Bioinformatics Corporation announced the commercial release of its novel Protein Kinase Microarray with 200 recombinant human protein kinases for screening.
The microarray has wide utility including applications for drug target counter screening, to identify novel kinase substrates, establish kinase antibody specificities, and for the discovery and testing of protein kinase-protein and protein kinase-compound interactions.
The microarray has wide utility including applications for drug target counter screening, to identify novel kinase substrates, establish kinase antibody specificities, and for the discovery and testing of protein kinase-protein and protein kinase-compound interactions.
February 8, 2010 - Kinexus adds a Kinase Inhibitor Compound Profiling Service (KICP) to its service portfolio.
This new service is designed to assist researchers in ascertaining the specificity of lead compounds and their mechanisms of action for the selection of better drug candidates for clinical testing.
This new service is designed to assist researchers in ascertaining the specificity of lead compounds and their mechanisms of action for the selection of better drug candidates for clinical testing.
2007 Press Releases
November 13, 2007 - Kinexus a Finalist for the "Red Herring 100 Global" Award 2007
The Most Promising Private Technology Ventures in the World to be Celebrated at Event in Seattle, Washington
The Most Promising Private Technology Ventures in the World to be Celebrated at Event in Seattle, Washington
October 26, 2007 - New Kinexus Website with Technical & Educational Resources for Cell Signalling Research
New Knowledge Based Website for Biomedical Research
New Knowledge Based Website for Biomedical Research
Annual Reports
Annual Reports
Kinexus has not released annual reports in previous years. However, we expect to produce an annual report for 2010. If you would like to receive a copy of our next annual report, please send your request to humanresources@kinexus.ca.
Media Articles
Media Articles
Kinexus has provided this list of articles and feature news stories as a convenience but their inclusion does not imply endorsement of the content of these publications by Kinexus. Kinexus has no control over the content of these publications and assumes no responsibility for this third party content.
Click on each title to view a pdf document of the full article or a weblink.
Click on each title to view a pdf document of the full article or a weblink.
2006 Articles
Business Edge News
Mathematics stepping out of the shadows. Graduate student program gives industry a look at discipline’s uses.
June 22, 2006, Vol. 6, No. 13
Article by Nicole Standlund
Mathematics stepping out of the shadows. Graduate student program gives industry a look at discipline’s uses.
June 22, 2006, Vol. 6, No. 13
Article by Nicole Standlund
Future Pharmaceuticals
Kinase profiling: The mysteries unraveled.
2006, Vol. 1, pp 23-25
Interview with Dr. Steven Pelech
Kinase profiling: The mysteries unraveled.
2006, Vol. 1, pp 23-25
Interview with Dr. Steven Pelech
Cool Companies Magazine
It’s all about communication and control.
2006, Vol. 2, pp 44-45
Article by Dr. Steven Pelech
It’s all about communication and control.
2006, Vol. 2, pp 44-45
Article by Dr. Steven Pelech
2005 Articles
The Scientist
Kinase screening services probe signaling pathways.
May 2005, Vol. 19, No. 9, pp 33-34
Article by Lissa Harris
Kinase screening services probe signaling pathways.
May 2005, Vol. 19, No. 9, pp 33-34
Article by Lissa Harris
Drug Discovery News
Public proteomics: Kinexus launches KINET proteomics database.
September 2005
Article by Lisa Espenschade
Public proteomics: Kinexus launches KINET proteomics database.
September 2005
Article by Lisa Espenschade
2002 Articles
National Post
Patently wrong. Canada's billion-dollar drug industry will be at risk if patent laws are eroded
Wednesday, March 6, 2002, Page FP15
Article by Dr. Steven Pelech
Patently wrong. Canada's billion-dollar drug industry will be at risk if patent laws are eroded
Wednesday, March 6, 2002, Page FP15
Article by Dr. Steven Pelech
2001 Articles
The Globe & Mail
The marriage of IT and medicine. Vast computing power is being harnessed to help researchers better understand the mechanisms of disease and develop highly focused drug treatments tailored to patients' genetic makeup.
Tuesday, September 18, 2001, pages H1 and H5
Article by Kevin Marron
The marriage of IT and medicine. Vast computing power is being harnessed to help researchers better understand the mechanisms of disease and develop highly focused drug treatments tailored to patients' genetic makeup.
Tuesday, September 18, 2001, pages H1 and H5
Article by Kevin Marron
The Globe & Mail
A scientist’s sacrilege: Making Money. Research into cell’s key proteins could prove life-saving.
Wednesday, January 3, 2001, page A6
Article by Anne McIlroy
A scientist’s sacrilege: Making Money. Research into cell’s key proteins could prove life-saving.
Wednesday, January 3, 2001, page A6
Article by Anne McIlroy
Biotechnology Focus
In pursuit of the proteome. The proteome mapping game is on.
July/August 2001 Issue, pages 18-20, 37
Article by Dr. Steven Pelech
In pursuit of the proteome. The proteome mapping game is on.
July/August 2001 Issue, pages 18-20, 37
Article by Dr. Steven Pelech
Red Herring
Kinexus tracks cellular conversations. Kinexus Bioinformatics Captures $1.2 Million.
Friday, March 23, 2001
Article by Steve Silverman
Kinexus tracks cellular conversations. Kinexus Bioinformatics Captures $1.2 Million.
Friday, March 23, 2001
Article by Steve Silverman
2000 Articles
The Vancouver Sun
Disease profile system developed by Kinexus Bioinformatics. Company's database tracks enzymes and their targets in cell and tissue specimens.
Wednesday, November 15, 2000, page D4
Article by Rod Nutt
Disease profile system developed by Kinexus Bioinformatics. Company's database tracks enzymes and their targets in cell and tissue specimens.
Wednesday, November 15, 2000, page D4
Article by Rod Nutt
The Globe & Mail
Venture firm set for banner year. Sector still eager to bet on startups despite meltdown in tech stocks.
Monday, October 30, 2000, page B1
Article by Peter Kennedy
Venture firm set for banner year. Sector still eager to bet on startups despite meltdown in tech stocks.
Monday, October 30, 2000, page B1
Article by Peter Kennedy
The Vacouver Province
Disease "snapshot". Vancouver Company first in the world to offer a commercial protein-screening process to treat diseases.
Wednesday, November 15, 2000, page A39
Article by Ashley Ford
Disease "snapshot". Vancouver Company first in the world to offer a commercial protein-screening process to treat diseases.
Wednesday, November 15, 2000, page A39
Article by Ashley Ford